USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
MATREXA, LLC
Address:
6524 44TH AVE NE
SEATTLE, WA
Phone:
N/A
URL:
N/A
EIN:
127057844
DUNS:
831396564
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
STTR Phase I $686,020.00 1

Award List:

Targeting the Extracellular Matrix to Inhibit Saphenous Vein Graft (SVG) Failure

Award Year / Program / Phase:
2011 / STTR / Phase I
Award Amount:
$686,020.00
Agency:
HHS
Principal Investigator:
Thomas N. Wight – 206-341-1377
Research Institution:
BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): The goal of this proposal is for Matrexa to develop a protein product that will prevent intimal hyperplasia in human saphenous vein grafts (SVG) with the objective of reducing the exceedingly high failure rate of thesesurgical procedures. The strategy involves… More